Moderna Melanoma Vaccine Succeeds in Phase 3 Trial

CHICAGO, United States — Moderna’s personalized mRNA cancer therapy Intismeran has delivered positive results in a late-stage melanoma trial conducted with Merck, sending Moderna shares sharply higher on Wednesday. The treatment, when combined with Merck’s Keytruda, met its main goal of reducing cancer recurrence and also achieved a key secondary goal involving the prevention of cancer spread.

Jitendra Singh Says India Is Set to Shape the Next Industrial Revolution With AI and Biotechnology

NEW DELHI, India — Union Minister Jitendra Singh said on Sunday that India is positioned to play a key role in the next industrial revolution, which he said is likely to be driven by biotechnology and artificial intelligence. Speaking at a media conclave attended by technology developers, industry leaders and other stakeholders, Singh said India had moved from being a technology follower to emerging as a global player across several frontier sectors.